Schlueter, M.
~ 300  Ergebnisse:
Personensuche X
?
1

Comparative efficacy and safety of targeted therapies for B..:

Corrie P ; Meyer N ; Berardi R...
info:eu-repo/semantics/altIdentifier/pmid/36099854.  , 2022
 
?
3

Cost-effectiveness analysis of baricitinib versus adalimuma..:

Schlueter M ; Finn E ; Díaz S...
https://www.dovepress.com/cost-effectiveness-analysis-of-baricitinib-versus-adalimumab-for-the-t-peer-reviewed-article-CEOR.  , 2019
 
?
6

T cells are functionally not impaired in AML: Increased PD-..:

Schnorfeil, F.M ; Lichtenegger, F.S ; Emmerig, K...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13045-015-0189-2.  , 2015
 
?
7

Detecting nanoparticles with SAXS:

de Jong, F. J ; Buffet, A ; Herzog, G...
https://bib-pubdb1.desy.de/record/141079.  , 2013
 
?
11

Structural Abnormalities of the Coronary Arterial Wall-in A..:

Liga, R ; Marini, C ; Coceani, M...
info:eu-repo/grantAgreement/EC/FP7/224297/EU/Multi-level patient-specific artery and atherogenesis model for outcome prediction, decision support treatment, and virtual hand-on training/ARTREAT.  , 2011
 
?
13

Practice patterns for antibiotic de-escalation in culture-n..:

Schlueter, M ; James, C ; Dominguez, A..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945711.  , 2010
 
1-15